Literature DB >> 9809517

Regulation of a blood-brain barrier-specific enzyme expressed by cerebral pericytes (pericytic aminopeptidase N/pAPN) under cell culture conditions.

M Ramsauer1, J Kunz, D Krause, R Dermietzel.   

Abstract

In this study we show that the aminopeptidase N of cerebral pericytes (pAPN) associated with the blood-brain barrier (BBB) is downregulated in pericytic cell cultures. This observation is in accordance with previous data describing comparable in vitro effects for BBB-specific enzymes of endothelial or pericytic origin, such as gamma-glutamyl transpeptidase or alkaline phosphatase. By polymerase chain reaction and in situ hybridization we were able to determine that the down-regulation of pAPN occurs at the posttranscriptional level. The mRNA of pAPN was found to be constitutively expressed even when the protein is no longer detectable. Culturing the pericytes in an endothelial cell-conditioned medium allowed pAPN to be reexpressed. However, the reexpression effect depended largely on the culturing conditions of the pericytes. Although purified pericytes deprived of endothelial cells did not reveal a reexpression effect, pericytes that were kept in contact with endothelial cells were able to acquire a pAPN-positive phenotype, indicating that endothelial cells constitute an essential requirement for the in vitro reexpression of pAPN. Astrocytes, however, were insufficient in exerting any reexpression effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809517     DOI: 10.1097/00004647-199811000-00014

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  13 in total

Review 1.  Blood-brain barrier dysfunction and recovery.

Authors:  A G de Boer; P J Gaillard
Journal:  J Neural Transm (Vienna)       Date:  2006-04       Impact factor: 3.575

2.  Bridging the gap between traditional cell cultures and bioreactors applied in regenerative medicine: practical experiences with the MINUSHEET perfusion culture system.

Authors:  Will W Minuth; Lucia Denk
Journal:  Cytotechnology       Date:  2015-04-17       Impact factor: 2.058

3.  Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.

Authors:  Yadollah Omidi; Jaleh Barar
Journal:  Bioimpacts       Date:  2012-02-02

4.  Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro.

Authors:  Jiabin Guo; Diana N Krause; James Horne; John H Weiss; Xuejun Li; Sue P Duckles
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-28       Impact factor: 6.200

5.  Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system.

Authors:  Li-Li Zou; Jie-Lan Ma; Tao Wang; Tang-Bin Yang; Chang-Bai Liu
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

Review 6.  Neural stem cell niches in health and diseases.

Authors:  Ilaria Decimo; Francesco Bifari; Mauro Krampera; Guido Fumagalli
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 7.  The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain.

Authors:  Gitanjali Sharma; Sushant Lakkadwala; Amit Modgil; Jagdish Singh
Journal:  Int J Mol Sci       Date:  2016-05-25       Impact factor: 5.923

Review 8.  Concise Review: The Regenerative Journey of Pericytes Toward Clinical Translation.

Authors:  William Cathery; Ashton Faulkner; Davide Maselli; Paolo Madeddu
Journal:  Stem Cells       Date:  2018-05-31       Impact factor: 6.277

Review 9.  Nanomaterials for Drug Delivery to the Central Nervous System.

Authors:  Daniel Mihai Teleanu; Irina Negut; Valentina Grumezescu; Alexandru Mihai Grumezescu; Raluca Ioana Teleanu
Journal:  Nanomaterials (Basel)       Date:  2019-03-05       Impact factor: 5.076

10.  Supportive development of functional tissues for biomedical research using the MINUSHEET® perfusion system.

Authors:  Will W Minuth; Lucia Denk
Journal:  Clin Transl Med       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.